Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 19, 2018
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - August 19, 2018

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

8/19/18 - FDA approves Teva's generic of Mylan's EpiPen [Jerusalem Post (Israel)]
The US Food and Drug Administration has approved Teva Pharmaceutical Industries Ltd. s generic version of Mylan NV s life-saving allergy injection, EpiPen, at a time when regulators are looking to lower healthcare costs. There has also been a shortage of EpiPen in North America, Europe and Canada since earlier this year due to manufacturing d
8/19/18 - Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
Health Canada is reviewing the long-term potential health impacts of the NDMA impurity on patients. Although Health Canada believes that the NDMA was introduced as a result of a change in manufacturing processes at Zhejiang Huahai Pharmaceuticals in 2012, some Canadian companies may have been using the affected valsartan active ingredient for less
8/19/18 - Procurement Of Veterinary Drugs, Vaccines, Medicines, Tools For The Treatment And Prevention Of Cattle [TendersInfo (India)]
Request for quotations: procurement of veterinary drugs, vaccines, medicines, tools for the treatment and prevention of cattle. 1. penikan p 2 000 pcs., 5 760 byn 2. dexamast 2 000 pcs., 5 040 byn 3. mamifort 1 500 pcs., 3 168 byn 4. mastodinon 1 500 pcs., 4 500 byn 5. ihglyukovit 100 liters, 840 byn. Date and time of the end of acceptance of offer
8/19/18 - Week Ahead In Pharmaceuticals: 7 Stocks To Watch (TNXP, REGN, KALA...)
Barely days after striking down Regeneron Pharmaceuticals Inc.' s request for an updated label for EYLEA, the FDA greenlighted the same on Friday, paving way for a 12- week dosing regimen of the drug for patients with wet age-related macular degeneration. Mylan's EpiPen, the most-widely prescribed epinephrine auto-injector in the U.S., and the one
8/18/18 - 'Pharmaceutical Packaging Market Worth Over $89.5 Billion in 2017' Says Visiongain Report
Visiongain, a independent media company, issued the following news release:. Visiongain's new report Pharmaceutical Packaging Market Report 2017-2027: Global Forecasts by Material, Product Delivery System and Geography indicates that the pharmaceutical packaging market will see over $89.5 bn in revenue in 2017.. The lead analyst of the report said:
8/18/18 - 11 Idaho counties take on Walmart, CVS, drug companies in opioid lawsuit [The Idaho Statesman]
Aug. 17 Several Idaho counties are suing drug makers and retailers, accusing them of being responsible for an opioid epidemic that has killed and harmed Idahoans. The lawsuit was filed Friday in federal court by Adams, Blaine, Boise, Bonneville, Caribou, Cassia, Elmore, Latah, Minidoka, Owyhee and Payette counties. "In Idaho, prescription opioid
8/18/18 - ActiGraph Announces New Scientific Affairs and Data Management Division [T-break Tech (Middle East)]
Guided by the novel endpoint development framework released by the Clinical Trials Transformation Initiative in 2017, ActiGraphs Scientific Affairs and Data Management division, headed by Director Tyler Guthrie, will facilitate joint research and development projects involving corporate partners and subject matter experts from within the...
8/18/18 - Aerie Reports Positive Study Results for Eye Pressure Drug Rhopressa
The North Carolina Biotechnology Center issued the following news release:. Aerie Pharmaceuticals, an ophthalmic pharmaceutical company based in Durham, has reported positive clinical results for Rhopressa, its once-daily eye drop approved for the reduction of elevated eye pressure, a cause of glaucoma. "This study confirms that in patients with e
8/18/18 - Albumin (As Excipient) Market to Reach US$ 1200 Mn by 2019
Albany, NY 08/18/2018 Global Albumin Market Snapshots. The global albumin market was valued at US$ 750 Mn in 2017 and is anticipated to reach US$ 1200 Mn by 2026 at a CAGR of over 5.0% from 2018 to 2026. For instance, in May 2017, China's Food and Drug Administration granted approval to clinical trials of human blood albumin produced from
8/18/18 - Army Seeks Tick-Borne Encephalitis Vaccine Development
The U.S. Army Medical Research Acquisition Activity has issued a sources sought notice for the development of tick-borne encephalitis vaccine for use by U.S. service members. Excerpts of the notice state: The vaccine must be European Medicines Agency approved, and shall achieve U.S. Food and Drug Administration licensure. For more information about
8/18/18 - As Opioid Overdose Deaths Increase, Senator Markey Queries FDA About Inappropriate Fentanyl Prescribing
An analysis of the FDA' s Risk Evaluation and Mitigations Strategies- a series of specific actions required by the FDA of a drug manufacturer that is intended to lessen the risks of the drug being sold- for this specific class of fentanyl medications indicated that 42 percent of these prescriptions may not have been prescribed appropriately.
8/18/18 - Bengaluru doctors pitch in for Kodagu, Kerala relief [New Indian Express (India)]
BENGALURU: The Karnataka Chapter of the Indian Medical Association has collected medicines worth Rs 15 lakh to Rs 20 lakh for distribution in flood-hit Kodagu district. "About 350 patients were attended to by the Indian Medical Association, Kodagu branch, and given first aid. Dr Anil Kumar B T, senior consultant nephrologist, BGS Global Hospital,
8/18/18 - Bunion (Hallux Valgus) Treatment Market Have Turned Into a $8 Billion Industry Growing at a CAGR of 6.5% - Forecast 2108-2023: Market Research Future published a study report on Bunion (Hallux Valgus) Treatment Market. This report studies the global
Pune, India 08/18/2018 Market Highlights:. A bunion is an enlargement of bone or tissue around the joint at the base of the big toe. The big toe may turn toward the second toe.
8/18/18 - China sacks six senior officials over vaccine scandal [New Indian Express (India)]
BEIJING: China has sacked six senior government officials for their neglect of duty and misconduct following a drug-safety scandal in which a pharmaceutical company manufactured substandard vaccines, including that for rabies, exported to India and other countries. Rabies vaccines made by the Changchun Changsheng Life Sciences Company, the second..
8/18/18 - Clear River Enviro Assigned Patent for Apparatus for Treating Pharmaceutical Waste
Clear River Enviro, Sugar Land, Texas, has been assigned a patent developed by four co-inventors for an "apparatus for treating pharmaceutical waste." The co-inventors are Michael Sanborn, Carrolton, Texas, Todd McGee, Mesa, Arizona, Mark Macdonell, Sugar Land, Texas, and Scott Kosch, Austin, Texas. Written by Subhashree Samal; edited by Sudarshan
8/18/18 - Company Profile for LuckyVitamin
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week Founded in 2005, LuckyVitamin is an industry-leading global e-commerce destination for health and wellness, natural and organic products, vitamins, nutritional supplements, sports and fitness nutrition, food, beauty, skincare, pet and natural home. LuckyVitamin offers premium
8/18/18 - County plans to join lawsuit against opioid manufacturers, distributors [The Daily Star-Journal, Warrensburg, Mo.]
Aug. 17 WARRENSBURG Johnson County commissioners plan to join a nationwide lawsuit against the manufacturers and distributors of opioids to recover funds spent in fighting and abating the opioid epidemic. Attorney Dirk Vandever of the Popham Law Firm, Kansas City, one of three law firms participating in the suit, said drug manufacturers and dis
8/18/18 - Drug Delivery Systems Market Projected to Reach US$ 900 Bn by 2019
Albany, NY 08/18/2018 Drug Delivery Systems Market: Snapshot. The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. For instance, on September 2017, Baxter International Inc. announced the launch of De
8/18/18 - EpiPen: NJ consumers squeezed by cost to get generic option from Teva [Asbury Park Press, N.J.]
Aug. 17 Families who rely on the expensive EpiPen to save their children during a severe allergy attack may soon have a lower-cost generic option thanks to a pharmaceutical company moving to New Jersey. "I think it's fantastic," said Amy McVey, 40, of Long Branch, whose 11- year-old son uses the injectable drug. Teva Pharmaceuticals Inc., the Is
8/18/18 - Evotec tapped for preclinical studies of BioTherapeutics lead candidate [Tehran Times (Iran)]
Mario Polywka, COO of the preclinical contract research organization Evotec, said in a press release, Our INDiGO platform reduces time and cost while consistently producing a quality data package for clinical trial agreements and investigational new drug filings. Mark Bamberger, CSO of Stealth stated, Our team at Stealth evaluated all options to he
8/18/18 - Faso Highlights FDA Approval of Generic EpiPen Auto-Injector
Rep. Faso had written to FDA Commissioner Dr. At the time, the FDA had just added epinephrine auto-injectors to the FDA' s list of existing drug shortages. I'm glad to see the FDA approve additional effective and safe devices that will lower costs for consumers and expand access. "
8/18/18 - FDA approves first generic competitor to EpiPen [T-break Tech (Middle East)]
It was approved after the FDA issued new guidance for generic copies of products like the EpiPen, which combines a drug with a specialized device to deliver it fast when people have life-threatening allergic reactions. This approval means patients living with severe allergies who require constant access to lifesaving epinephrine should have a lower
8/18/18 - FDA Clears SPR Therapeutics Non-opioid SPRINT endura and extensa Peripheral Nerve Stimulation Systems for Pain Management [Tehran Times (Iran)]
SPR Therapeutics, Inc., a leader in neurostimulation technology for pain, today announced that the U.S. Food and Drug Administration has cleared its SPRINTendura and extensa Peripheral Nerve Stimulation Systems. With the ease of use and dual lead capabilities weve built into the SPRINT System we look forward to advancing the early use of neurostimu
8/18/18 - FDA gives green light to study of cholangiocarcinoma drug [Tehran Times (Iran)]
Sirnaomics, Inc., a biopharmaceutical company in discovery and development of RNAi therapeutics, announces that the U.S. Food and Drug Administration has approved the companys first oncology IND application. Although it is more common in Asia, its incidence in Europe and North America has increased significantly in recent decades. In 2017, STP705 w
8/18/18 - FSD Pharma and SciCann Therapeutics Launch Clinical Research Program in Israel [T-break Tech (Middle East)]
FSD Pharma Inc. has announced the launch of a clinical research collaborative program in Israel, via its strategic R&D partner, SciCann Therapeutics Inc.. As announced previously, FSD Pharma has secured the exclusive licensing rights for the manufacturing and distribution of SciCann`s line of proprietary, patent-pending, cannabinoid-based and...
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415